Search Results - "Holly, Alesia"

  • Showing 1 - 9 results of 9
Refine Results
  1. 1
  2. 2

    Oncogenesis driven by the Ras/Raf pathway requires the SUMO E2 ligase Ubc9 by Yu, Bing, Swatkoski, Stephen, Holly, Alesia, Lee, Liam C., Giroux, Valentin, Lee, Chih-Shia, Hsu, Dennis, Jordan, L. Smith, Yuen, Garmen, Yue, Junqiu, Ann, David K., Simpson, R. Mark, Creighton, Chad J., Figg, William D., Gucek, Marjan, Luo, Ji

    “…Significance Currently there are no targeted therapies for KRAS mutant cancer. Our study uncovers a critical role of the small ubiquitin-like modifier (SUMO)…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Polylactide-based paclitaxel-loaded nanoparticles fabricated by dispersion polymerization: characterization, evaluation in cancer cell lines, and preliminary biodistribution studies by Adesina, Simeon K, Holly, Alesia, Kramer-Marek, Gabriela, Capala, Jacek, Akala, Emmanuel O

    Published in Journal of pharmaceutical sciences (01-08-2014)
    “…The macromonomer method was used to prepare cross-linked, paclitaxel-loaded polylactide (PLA)-polyethylene glycol (stealth) nanoparticles using free-radical…”
    Get more information
    Journal Article
  5. 5

    Abstract B29: A critical role of the SUMO pathway in KRAS-driven oncogenesis by Yu, Bing, Swatkoski, Steve, Holly, Alesia, Lee, Liam Changwoo, Giroux, Valentin, Lee, Chih-Shia, Carver, Joseph, Creighton, Chad, Ann, David K., Figg, William Douglas, Gucek, Marjan, Luo, Ji

    Published in Molecular cancer research (01-12-2014)
    “…Abstract The SUMOylation pathway modulates the activity of many cellular proteins and plays an important role in cellular stress protection. We identified the…”
    Get full text
    Journal Article
  6. 6

    Disruption of the HIF‐1α/p300 interaction as a means of inhibiting angiogenesis by Reece, Kelie M, Richardson, Emily D, Pisle, Stephen T, Holly, Alesia J, Campbell, Tessa J, Figg, William D

    Published in The FASEB journal (01-04-2012)
    “…Abstract only Solid tumors develop regions of hypoxia because of an imbalance in oxygen supply and consumption. Thus, adaptation of cancer cells to hypoxia is…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Frequent codon 12 Ki-ras mutations in mouse skin tumors initiated by N-methyl-N′-nitro-N-nitrosoguanidine and promoted by mezerein by Rehman, Ishtiaq, Lowry, David T., Adams, Cameron, Abdel-Fattah, Rana, Holly, Alesia, Yuspa, Stuart H., Hennings, Henry

    Published in Molecular carcinogenesis (01-04-2000)
    “…The skin tumor initiators N‐methy‐N′‐nitro‐N‐nitrosoguanidine (MNNG) and 7,12‐dimethylbenz[a]anthracene (DMBA) differ in effectiveness when tumor formation is…”
    Get full text
    Journal Article
  9. 9